Skip to main content
. Author manuscript; available in PMC: 2024 Mar 30.
Published in final edited form as: Semin Neurol. 2014 Apr 8;34(1):61–69. doi: 10.1055/s-0034-1372343

Table 3.

Treatment for CNS toxoplasmosis in HIV

Chronic suppressive therapy or secondary prophylaxis (duration determined by response to cART)
Pyrimethamine plus 25–50 mg PO every d
Sulfadiazine or Clindamycin plus 1 g PO bid–qid 600 mg PO tid
Folinic acid (leucovorin) 10 – 50 mg PO every d

Abbreviations: bid, twice daily; cART, combination antiretroviral therapy; CNS, central nervous system; HIV, human immunodeficiency virus; IV, intravenous; PO, by mouth; qid, 4 times a day; tid, three times a day.

Source: Table data from92.